This guide provides academic and industrial investigators with analytical specifications, structural data, and sourcing criteria for high-purity Tesamorelin. All information is presented strictly for in vitro and preclinical laboratory research contexts.
This guide provides academic and industrial investigators with analytical specifications, structural data, and sourcing criteria for high-purity Tesamorelin. All information is presented strictly for in vitro and preclinical laboratory research contexts.
When executing a tesamorelin peptide purchase for laboratory research use only, institutional investigators must ensure compound identity, batch purity exceeding 98%, and verified low endotoxin levels. Tesamorelin is a synthetic 44-amino acid growth hormone-releasing hormone (GHRH) analog featuring a trans-3-hexenoic acid group attached to the N-terminus, providing enhanced metabolic stability for preclinical studies.
Evaluating chemical suppliers requires reviewing lot-specific documentation, including high-performance liquid chromatography (HPLC) chromatograms and mass spectrometry (MS) characterization. Sourcing from accredited USA facilities ensures that research reagents conform to rigorous quality control protocols and maintain structural integrity during transport and storage.
Tesamorelin (sequence: Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2) is an engineered peptide derivative of human growth hormone-releasing hormone (GHRH 1-44). The addition of the trans-3-hexenoic acid moiety at the amino-terminal leucine residue significantly reduces susceptibility to enzymatic cleavage by dipeptidyl peptidase-4 (DPP-4) compared to endogenous GHRH.
In vitro receptor binding assays demonstrate that Tesamorelin selective binds to the GHRH receptor (GHRHR) on pituitary somatotrophs with high affinity. This interaction stimulates the adenylate cyclase/cAMP signaling cascade, downstream activation of protein kinase A (PKA), and subsequent transcription and pulsatile secretion of endogenous growth hormone (GH). In preclinical models, this targeted receptor engagement drives hepatic synthesis of insulin-like growth factor 1 (IGF-1) without disrupting negative feedback regulation of cortisol or thyroid hormone axes.
Preclinical studies suggest that Tesamorelin plays a key role in modulating lipid metabolism, visceral adipose tissue attenuation, and cellular repair pathways. Investigators utilizing animal models have observed that GHRHR signaling via Tesamorelin activation accelerates lipolysis within visceral adipocytes by upregulation of hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL).
Furthermore, rodent and non-human primate research indicates that downstream IGF-1 elevation induced by Tesamorelin supports nitrogen retention, skeletal muscle protein synthesis, and extracellular matrix remodeling. In vitro data indicate that exposure to Tesamorelin enhances mitochondrial bioenergetics in mammalian cell culture models, providing a valuable framework for investigating metabolic regulation, peripheral nerve regeneration, and hepatic lipid oxidation.
To select the appropriate secretagogue for specific experimental parameters, researchers frequently compare Tesamorelin against other compounds within the secretagogue class. While Tesamorelin is a full-length 44-amino acid GHRH derivative with an N-terminal hexenoyl modification, Sermorelin represents a truncated 29-amino acid fragment (GHRH 1-29) possessing a significantly shorter plasma half-life in rodent models.
Conversely, CJC-1295 DAC is a modified GHRH 1-29 fragment engineered with a Drug Affinity Complex that covalently binds to plasma albumin, resulting in extended half-life dynamics contrasting with the pulsatile release profile elicited by Tesamorelin. When evaluating growth hormone secretagogues (GHS), researchers often pair GHRH analogs with selective ghrelin receptor agonists such as Ipamorelin to evaluate synergistic GH release pathways in cell culture or animal assays. Reviewing our comprehensive GHRH analogs guide helps clarify structural distinctions across our entire catalog of research peptides.
Assuring analytical purity is critical when placing a Tesamorelin order for sensitive bioassays. Standard analytical protocols require reverse-phase high-performance liquid chromatography (RP-HPLC) to establish chemical purity standards above 98.0%, confirming the absence of truncated sequences, truncated deletion peptides, or residual protecting groups from solid-phase peptide synthesis (SPPS).
Electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) must be performed on every production lot to confirm exact monoisotopic mass (molecular mass approx. 5135.9 Da). Additionally, because bacterial endotoxins (lipopolysaccharides) can confound cell culture viability and induce non-specific inflammatory signaling in animal models, qualified lots undergo Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels below 0.1 EU/mg. Investigators can consult our endotoxin testing standards resource for deeper insights into threshold metrics.
Lyophilized Tesamorelin is supplied as a sterile, vacuum-sealed cake or powder. For primary laboratory reconstitution, bacteriostatic water containing 0.9% benzyl alcohol or sterile 0.9% sodium chloride solution is recommended, depending on the requirements of downstream assays.
To perform reconstitution: sanitize the vial stopper with 70% isopropyl alcohol, insert a sterile needle against the inner glass wall, and slowly introduce the desired volume of diluent (e.g., 1 mL or 2 mL) to achieve a calculated concentration (e.g., 2 mg/mL or 5 mg/mL). Gently swirl the vial until complete dissolution is observed; avoid vigorous vortexing or shaking, which can cause mechanical shear stress, peptide aggregation, or foam formation. Detailed step-by-step procedures are outlined in our peptide reconstitution guide.
Lyophilized Tesamorelin demonstrates high stability when stored under controlled temperature conditions. For long-term preservation prior to reconstitution, freeze vials at -20°C to -80°C, protected from light exposure and atmospheric moisture. Under these conditions, the intact lyophilized peptide retains chemical stability for up to 24 months.
Following reconstitution, liquid solutions should be kept refrigerated at 2°C to 8°C and utilized within 28 days if reconstituted with bacteriostatic water. For short-term assays using unpreserved sterile water, solutions must be used immediately or divided into single-use aliquots and frozen at -80°C to prevent degradation from freeze-thaw cycles.
Procuring research compounds requires validating supplier credentials to ensure experimental reproducibility and compliance. Principal investigators and laboratory managers should verify that the manufacturer operates under cGMP-compliant facilities and utilizes ISO 17025 accredited analytical laboratories for third-party validation.
Key criteria when finalizing a research peptide procurement include batch-specific Certificate of Analysis (COA) availability, full lot traceability from synthesis through packaging, and secure handling protocols. Universities, biotechnology firms, and institutional laboratories seeking bulk volume pricing or customized container sizes can submit inquiries via our wholesale portal or review detailed technical whitepapers in our main peptide research hub.
PX1 Research is dedicated to supplying North American research institutions with premium, USA-manufactured research peptides. Every lot of Tesamorelin undergoes rigorous quality control testing including RP-HPLC purity analysis, mass spec identity confirmation, and LAL endotoxin quantification prior to release.
Orders are processed from our modern distribution hubs in California and Arizona, offering same-day dispatch for orders placed Monday through Friday prior to cut-off times. All shipments are packaged in temperature-controlled, secure containers to preserve structural integrity during transit, ensuring your laboratory receives verified, highly reproducible research reagents.
What is Tesamorelin and what is its primary biological target?
Tesamorelin is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) with an N-terminal trans-3-hexenoic acid modification. Its primary target is the GHRH receptor on pituitary somatotrophs, where it stimulates endogenous GH production and downstream IGF-1 signaling in preclinical models.
How is Tesamorelin purity verified prior to purchase?
Every lot of Tesamorelin at PX1 Research is subjected to reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity (>98%) and electrospray ionization mass spectrometry (ESI-MS) to confirm exact molecular mass.
What endotoxin threshold is maintained for PX1 Research Tesamorelin?
PX1 Research enforces strict quality thresholds where every batch undergoes Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.1 EU/mg, preventing confounding non-specific immune responses in laboratory models.
What diluent should be used to reconstitute Tesamorelin for laboratory use?
Bacteriostatic water (0.9% benzyl alcohol) is typically used for multi-use laboratory preparations, while sterile 0.9% saline or sterile water for injection is utilized for immediate in vitro cell culture protocols requiring alcohol-free media.
How should lyophilized Tesamorelin be stored upon arrival?
Lyophilized Tesamorelin should be stored at -20°C to -80°C in a dry, dark environment. Upon receipt, unconstituted vials remain stable for up to 24 months when maintained under sub-zero conditions.
How does Tesamorelin differ structurally from Sermorelin?
Tesamorelin contains the complete 44-amino acid sequence of native GHRH modified with a hexenoyl group at the N-terminus, whereas Sermorelin is a truncated 29-amino acid sequence (GHRH 1-29) without hexenoyl stabilization.
Can Tesamorelin be purchased for human consumption or medical treatment?
No. All products sold by PX1 Research, including Tesamorelin, are strictly intended for laboratory research use only by qualified investigators. They are not for human or animal consumption, diagnostic, or therapeutic use.
Where does PX1 Research manufacture and ship its peptides?
PX1 Research peptides are manufactured in USA-based cGMP-compliant facilities and dispatched directly from our distribution centers located in California and Arizona, offering same-day shipping on business days.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.